119-SJRES-83 Journalist Public Summary

Headline Summary

Stops unauthorized U.S. military action against newly designated terrorist or drug‑trafficking groups unless Congress votes to allow it.

What It Does

S.J.Res. 83 directs the President to end U.S. armed‑forces involvement in hostilities against three categories—(1) any group labeled a foreign terrorist organization (FTO) or specially designated global terrorist on or after February 20, 2025, (2) any state where those groups operate, and (3) any non‑state drug‑trafficking organizations—unless Congress passes a declaration of war or a specific authorization for use of military force (AUMF). It affirms that the U.S. can still act in genuine self‑defense against an armed attack or imminent armed attack and can support domestic counternarcotics operations, but clarifies that drug trafficking alone does not equal an armed attack.

• Cites Congress’s constitutional war‑powers and the War Powers Resolution as the framework for requiring authorization.
• Responds to recent U.S. strikes at sea by noting Congress has not received sufficient details about targets, threats, or legal justifications.
• Narrowly preserves immediate self‑defense and assistance to civil authorities while limiting open‑ended overseas uses of force tied to drug trafficking.

Who’s For It

• Sponsors: Senators Adam Schiff (D‑CA) and Tim Kaine (D‑VA).
• Likely supporters: lawmakers who prioritize reasserting congressional war‑powers; civil‑liberties and anti‑war advocates who want tighter limits on unilateral military action.
• Their case: Congress—not the executive—should decide when the U.S. enters new conflicts; requiring a vote increases transparency, prevents mission creep, and ensures any campaign targeting cartels or newly designated terrorist groups has clear legal footing and oversight.

Who’s Against It

• Potential opponents: national‑security hawks and some in the executive branch who argue the President needs flexibility to act quickly against cartels or emergent terrorist threats without waiting for Congress.
• Their case: strict preauthorization could slow responses, telegraph constraints to adversaries, and complicate multinational or maritime operations aimed at disrupting drug flows or proxy actors.

What’s Next

Introduced in the Senate on September 18, 2025, and referred to the Foreign Relations Committee. Next steps could include a hearing and committee vote; if approved, it would move to the full Senate, then the House. As a joint resolution, it would go to the President if passed by both chambers; a veto would require two‑thirds majorities in each chamber to override.